These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4846488)

  • 21. Modification by passive IgM of the immune response of mice to a tumor allograft.
    Cantrell JL; Kaliss N
    J Natl Cancer Inst; 1974 May; 52(5):1619-25. PubMed ID: 4831447
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum immunoglobulin levels in mice bearing a chemically induced sarcoma.
    Merino F
    Oncology; 1974; 30(2):141-6. PubMed ID: 4449631
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhancement of immunogenicity of a BALB-c myeloma protein in BALB-c mice.
    Peaker PJ; Cicurei L; Nisonoff A
    J Immunol; 1974 Sep; 113(3):791-7. PubMed ID: 4213082
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppressor cells as an agent of immune facilitation. II. Adoptive transfer of passively induced enhancement of allografted tumors.
    Douvas GS; Kinsky RG; Duc HT; Voisin GA
    Cell Immunol; 1982 Apr; 68(2):389-401. PubMed ID: 6212126
    [No Abstract]   [Full Text] [Related]  

  • 25. ["In vivo" suppression of immunoglobulin synthesis in mice by treatment with anti-mu chain antibodies: the effect on IgG1, IgG2 and IgM levels].
    Mathieu C; Stanislawski M
    Ann Immunol (Paris); 1974; 125 C(5):715-29. PubMed ID: 4218466
    [No Abstract]   [Full Text] [Related]  

  • 26. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM; Millar RC; Ketcham AS
    Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms of immunological enhancement.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
    Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
    [No Abstract]   [Full Text] [Related]  

  • 28. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
    Jansen JL; Gerard AP; Kamp J; Tamboer WP; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):387-91. PubMed ID: 807636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated immunoglobulins. The elution of IgG2 from mouse tumors.
    Ran M; Witz IP
    Int J Cancer; 1970 Nov; 6(3):361-72. PubMed ID: 5486605
    [No Abstract]   [Full Text] [Related]  

  • 30. Similar activities of IgG1 and IgG2 alloantibodies in enhancement of mouse skin grafts and in opsonization.
    Lems SP; Rijke-Schilder TP; Capel PJ; Koene RA
    Transplantation; 1984 Mar; 37(3):291-6. PubMed ID: 6701959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 32. Transfer of mouse IgG2 production by IgM-bearing spleen cells separated by a fluorescence-activated cell sorter.
    Bankhurst AD; Anderson RE; Cram LS; Horan PH; Warner NL
    Aust J Exp Biol Med Sci; 1978 Oct; 56(5):571-7. PubMed ID: 375904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the opsonic activity of purified bovine sIgA following intramammary immunization of cows with Staphylococcus aureus.
    Barrio MB; Rainard P; Gilbert FB; Poutrel B
    J Dairy Sci; 2003 Sep; 86(9):2884-94. PubMed ID: 14507024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The allogeneic bisection of carrier-specific enhancement of monoclonal B-cell responses.
    Pierce SK; Klinman NR
    J Exp Med; 1975 Nov; 142(5):1165-79. PubMed ID: 811749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of radiolabeled mouse alloantibody in a sarcoma induced by 3-methylcholanthrene.
    Buchsbaum DJ; Loken MK; Johnson EA; Walker PC; Ponto RA
    J Nucl Med; 1980 Jan; 21(1):77-80. PubMed ID: 7356743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Enzyme-linked immunosorbent assay (ELISA) for the demonstration of IgG1, IgG2 and IgM antibodies in bovine Q fever infection].
    Schmeer N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Feb; 259(1):20-34. PubMed ID: 4002933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of rat tumor allografts on the blood level of passively transferred alloantibodies.
    Buchsbaum DJ
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1197-201. PubMed ID: 4112429
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice.
    Coulie PG; Van Snick J
    Eur J Immunol; 1985 Aug; 15(8):793-8. PubMed ID: 4029257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of bovine immunoglobulin G2 antibodies binding Staphylococcus aureus, using a murine monoclonal antibody.
    Mathison BA; Kelley KW; Davis WC
    Am J Vet Res; 1984 Dec; 45(12):2518-24. PubMed ID: 6395731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.